KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (2016 - 2025)

Moderna (MRNA) has disclosed Shares Outstanding for 10 consecutive years, with $394.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2.07% to $394.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $394.0 million through Dec 2025, up 2.07% year-over-year, with the annual reading at $394.0 million for FY2025, 2.07% up from the prior year.
  • Shares Outstanding for Q4 2025 was $394.0 million at Moderna, up from $391.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $405.0 million in Q3 2021, with the low at $381.0 million in Q2 2023.
  • Average Shares Outstanding over 5 years is $390.2 million, with a median of $387.0 million recorded in 2022.
  • The sharpest move saw Shares Outstanding increased 8.38% in 2021, then decreased 4.47% in 2022.
  • Over 5 years, Shares Outstanding stood at $403.0 million in 2021, then fell by 4.47% to $385.0 million in 2022, then decreased by 0.78% to $382.0 million in 2023, then rose by 1.05% to $386.0 million in 2024, then grew by 2.07% to $394.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $394.0 million, $391.0 million, and $389.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.